Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Research

| More

Balrampur Chini - Q1FY21 First Cut - ICICI Securities

Posted On: 2020-08-07 23:36:58


(CMP - Rs. 130; MCap - Rs. 2867 crore)

Balrampur Chini reported strong set of numbers with 50.8% increase in revenues & 24.9% increase in net profit.

Q1FY21 Earnings Summary

- Revenues were higher by 50.8% to Rs. 1430.8 crore on account of 60% increase in both sugar & distillery sales. The increase in sugar sales was aided by higher domestic quota & exports during the quarter. Our estimates suggest, the company would have sold 2.9 lakh tonnes of sugar in domestic market & 0.6 lakh tonnes through exports. The higher distillery sales was driven higher volumes as the company commissioned 160 KLD new distillery in January 2020. Moreover, distillery realisation would have also been higher with the higher proportion of B heavy ethanol

- Power sales was down by 13.5% to Rs. 95.7 crore mainly on account of lower volumes as company would have sold some quantities of bagasse during the quarter. Moreover, power realisation have remained down given revision in power tariffs last year

- Operating profit increased by 23.9% to Rs. 217.9 crore with higher sugar & ethanol sales during the quarter. Operating margins was down 330 bps mainly due to gross margin contraction. We believe average sugar realisation would have been lower compared to last year given sugar prices fell to Rs. 31/kg in April & May due to lockdown conditions imposed across country. Net profit grew by 24.9% to Rs. 139.5 crore

The company has exported ~2.8 lakh tonnes of sugar in current sugar season. Moreover, it has been able to sell higher sugar quantities in domestic market through higher sale quota. Further, sugar production for Balrampur Chini in 2019-20 sugar season not increased despite higher sugarcane availability. The company has been able to sacrifice sufficient sugar quantities through the production of B heavy molasses. We believe the company is in a position to liquidate its current season inventory by November-December 2020, which is far better position than industry (it would be carrying just a months in inventory compared to average 5 months inventory by industry). The company would see higher distillery volumes with full year of new distillery operations & higher ethanol realisation with more diversion towards B heavy ethanol. Balrampur chini is most efficient sugar company in India with no high cost long term debt & least working capital debt requirement. We remain positive on the stock.

We will be coming out with the detailed update soon.

Shares of BALRAMPUR CHINI MILLS LTD. was last trading in BSE at Rs.130.2 as compared to the previous close of Rs. 127.6. The total number of shares traded during the day was 200650 in over 3256 trades.

The stock hit an intraday high of Rs. 132.3 and intraday low of 125. The net turnover during the day was Rs. 26103292.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Mazagon Dock IPO fully subscribed on Day 1 - Angel Broking

Pharma - Sector Thematic - Cardiac: the heartbeat of domestic market - HDFC Securities Institutional Research Desk

Walmart-Tata Retail Deal - Mr. Himanshu Nayyar, YES SECURITIES

HDFC Securities Institutional Research Desk: Chemical Conference Report

Lupin - Launch of Fosaprepitant - Angel Broking

Infosys - Key beneficiary of increased IT spending - Angel Broking

Gateway Distriparks - Holding structure simplified; prepared for next phase of growth - ICICI Securities

Visaka Industries - Demand and pricing tailwinds sustain; maintain a compelling BUY - ICICI Securities

GSK Pharmaceuticals - Analyst call highlights - Sep 28, 2020 - ICICI Securities

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Healthcare - Diagnostics: Multiple tailwinds likely to emerge - ICICI Securities

Mazagon Dock Shipbuilders Ltd - IPO Review - ICICI Securities

Persistent Systems - 28th September 2020 - Angel Broking

Canara Bank - 28th September 2020 - Angel Broking

Subscribe to UTI Asset Management Company Limited - IPO Note - Angel Broking

Multiplex Sector - Mr. Jyoti Roy - DVP - Equity Strategist, Angel Broking Ltd

Sale of Sequent stake to Strides Pharma - Angel Broking

Subscribe to Mazagon Dock Shipbuilders Ltd - IPO Note - Angel Broking

JSW Energy - First big renewable step - ICICI Securities

V-MART Retail - Best play in value fashion segment; initiating with BUY - ICICI Securities

Gas sector - New winners and losers likely on policy changes in gas sector - ICICI Securities

Mazagon Dock Shipbuilders Limited - IPO Note - Geojit

UTI Asset Management Company Limited - IPO Note - Geojit

Preview on RBI Monetary Policy - Oct 2020 - Shanti Ekambaram

Rollover Report for September 2020 - October 2020: Angel Broking

Covid Recovery Pulse - Sep 25, 2020 - ICICI Securities

Quick Comment - Suven Pharmaceuticals - ICICI Securities

Derivatives Strategy - Sep 25, 2020 - Positional Option - ICICI Securities

Gladiator Stocks - Ramco Cement - ICICI Securities

IPO Review - UTI Asset Management Company - ICICI Securities

Stock of the Day - Zensar Technologies - Sep 25, 2020 - Angel Broking

Accenture Q4FY2020 Result - Angel Broking

Granules India receives ANDA approval - Angel Broking

Zydus Cadila receives US FDA approval - Angel Broking

Cipla - ANDA approval - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Mindspace REIT - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

UTI AMC - IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

Balkrishna Industries - Growth momentum continues - ICICI Securities

Rollover Analysis (September 25): Nifty starts October series with low OI amid high volatility

Derivatives View (September 25): Sell Bank Nifty in range of 20650-20750 - ICICI Securities

Rollover Analysis - Sept 20: Selling climax on expiry as markets crumble - YES Securities

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019